GEHC Stock Overview
Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
GE HealthCare Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$364,220.00 |
| 52 Week High | US$385,700.00 |
| 52 Week Low | US$353,560.00 |
| Beta | 0 |
| 11 Month Change | -6.23% |
| 3 Month Change | 6.59% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 12.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| GEHC | CO Medical Equipment | CO Market | |
|---|---|---|---|
| 7D | -2.5% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how GEHC performed against the CO Medical Equipment industry.
Return vs Market: Insufficient data to determine how GEHC performed against the CO Market.
Price Volatility
| GEHC volatility | |
|---|---|
| GEHC Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in CO Market | 0% |
| 10% least volatile stocks in CO Market | 0% |
Stable Share Price: GEHC has not had significant price volatility in the past 3 months compared to the CO market.
Volatility Over Time: Insufficient data to determine GEHC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 51,000 | Pete Arduini | www.gehealthcare.com |
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products.
GE HealthCare Technologies Inc. Fundamentals Summary
| GEHC fundamental statistics | |
|---|---|
| Market cap | Col$166.34t |
| Earnings (TTM) | Col$7.40t |
| Revenue (TTM) | Col$86.38t |
22.5x
P/E Ratio1.9x
P/S RatioIs GEHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GEHC income statement (TTM) | |
|---|---|
| Revenue | US$19.56b |
| Cost of Revenue | US$11.47b |
| Gross Profit | US$8.09b |
| Other Expenses | US$6.41b |
| Earnings | US$1.68b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.67 |
| Gross Margin | 41.34% |
| Net Profit Margin | 8.56% |
| Debt/Equity Ratio | 121.2% |
How did GEHC perform over the long term?
See historical performance and comparison